Population
Rats (in vivo) and washed platelets/platelet lysate
Design
Preclinical
Authors
Loading...
Animal mechanism data on ticlopidine; leaves open translation to human antiplatelet therapy.
Ticlopidine inhibits platelet aggregation by increasing platelet cAMP levels via activation of adenylate cyclase.
Ashida et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: